Tyvaso

United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
United Therapeutics Stops Late-Stage Tyvaso Study In Lung Disease
Yahoo/Benzinga
United Therapeutics
Tyvaso
COPD
clinical trials
Flag link:
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
Long after first nod for inhaled Tyvaso, United Therapeutics scraps PhIII in PH with COPD
Endpoints
Tyvaso
United Therapeutics
PAH
clinical trials
Flag link:
FDA declines to approve United-MannKind's lung disease therapy
FDA declines to approve United-MannKind's lung disease therapy
Yahoo/Reuters
MannKind
United Therapeutics
Tyvaso
FDA
PAH
Flag link:
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
MannKind and United Snag Priority Review for Pulmonary Hypertension Drug
BioSpace
MannKind
United Therapeutics
PAH
PH-ILD
FDA
priority review
Tyvaso
Flag link:
United Therapeutics: FDA Approves Tyvaso For PH-ILD
United Therapeutics: FDA Approves Tyvaso For PH-ILD
NASDAQ
United Therapeutics
FDA
Tyvaso
PH-ILD
pulmonary hypertension
Flag link:
With pipeline setbacks mounting, United snares priority voucher for inhaled formulation of PAH med Tyvaso
With pipeline setbacks mounting, United snares priority voucher for inhaled formulation of PAH med Tyvaso
Endpoints
United Therapeutics
Tyvaso
priority review voucher
PAH
Flag link:
GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics
GSK-backed Liquidia takes a seat at the IPO table, looking for a $57.5M stake to take on United Therapeutics
Endpoints
Liquidia
IPOs
PAH
United Therapeutics
Tyvaso
Flag link:
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Medicare
H.P. Acthar Gel
Mallinckrodt
Remodulin
United Therapeutics
Tyvaso
Provenge
Valeant Pharmaceuticals
Gilead Sciences
Harvoni
Flag link:
United Therapeutics receives subpoena for 3 drugs
United Therapeutics receives subpoena for 3 drugs
Yahoo/AP
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
pulmonary arterial hypertension
Flag link:
United Therapeutics Could Lose The Battle For PAH Therapies
United Therapeutics Could Lose The Battle For PAH Therapies
TheStreet.com
United Therapeutics
PAH
Remodulin
Tyvaso
Adcirca
Flag link:
United Therapeutics Grows With Drugs For Rare Diseases
United Therapeutics Grows With Drugs For Rare Diseases
Investors.com
United Therapeutics
Remodulin
Adcirca
Tyvaso
PAH
Flag link:
United Therapeutics pulls Tyvaso application
United Therapeutics pulls Tyvaso application
Yahoo/AP
United Therapeutics
Tyvaso
Europe
Flag link:
United Therapeutics' Growth Driven By Approval Of Two New Treatments
United Therapeutics' Growth Driven By Approval Of Two New Treatments
Yahoo/Investors Business Daily
United Therapeutics
Pfizer
Eli Lilly
Gilead Sciences
Tyvaso
Adcirca
Flag link:
United Therapeutics: Gold Star Performance as Second FDA Approval Confirmed
United Therapeutics: Gold Star Performance as Second FDA Approval Confirmed
Seeking Alpha
FDA
United Therapeutics
Tyvaso
Flag link:
FDA Calendar Updates: United Therapeutics, Roche
FDA Calendar Updates: United Therapeutics, Roche
Seeking Alpha
Roche
United Therapeutics
Tyvaso
Lucentis
Flag link:
United Therapeutics says FDA now plans to rule on inhaled blood pressure drug by July 30
United Therapeutics says FDA now plans to rule on inhaled blood pressure drug by July 30
Yahoo/AP
United Therapeutics
FDA
hypertension
Tyvaso
Flag link:
United Therapeutics Drops On Delay
United Therapeutics Drops On Delay
Forbes
United Therapeutics
hypertension
Tyvaso
Flag link: